| Treating prehypertension: a review of the evidence. | |
| | |
MedLine Citation:
|
PMID: 18625164 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Although the term "prehypertension" has been challenged by some, its use to define people with systolic blood pressure (BP) between 120 and 139 mm Hg and/or diastolic pressures between 80 and 89 mm Hg has gained general acceptance. The category includes as many people as the number who have hypertension, defined as blood pressure of 140/90 or above. Such people are clearly at an increased risk of cardiovascular damage compared with people with BPs below 120/80 mm Hg. The major unresolved issue is the appropriate management of such patients. Two trials have attempted to document the value of short-term drug therapy to prevent the progression of BP to overt hypertension, but no outcome studies are currently available. |
| | |
Authors:
|
Norman M Kaplan |
Related Documents
:
|
19746294 - Effect of device-guided breathing exercises on blood pressure in patients with hyperten... 7009424 - Influence of hospitalization and placebo therapy on blood pressure and sympathetic func... 18464744 - Prognostic relevance of masked hypertension in subjects with prehypertension. 15249794 - Comprehensive lifestyle modification and blood pressure control: a review of the premie... 80634 - Innappropriate renin secretion unmasked by captopril (sq 14 225) in hypertension of chr... 18384624 - Impaired nitroglycerin biotransformation in patients with chronic heart failure. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current hypertension reports Volume: 10 ISSN: 1534-3111 ISO Abbreviation: Curr. Hypertens. Rep. Publication Date: 2008 Aug |
Date Detail:
|
Created Date: 2008-07-15 Completed Date: 2008-09-25 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100888982 Medline TA: Curr Hypertens Rep Country: United States |
Other Details:
|
Languages: eng Pagination: 326-9 Citation Subset: IM |
Affiliation:
|
University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 25390, USA. norman.kaplan@utsouthwestern.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiotensin II Type 1 Receptor Blockers
/
therapeutic use Animals Blood Pressure / drug effects* Cardiovascular Diseases / prevention & control Genetic Predisposition to Disease Humans Hypertension / genetics Randomized Controlled Trials as Topic |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin II Type 1 Receptor Blockers |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Insulin resistance and blood pressure.
Next Document: Pharmacologic considerations in the positioning of beta-blockers in antihypertensive therapy.